Application
Fig1: Western blot analysis of RND3 on human RND3 recombinant protein using anti-RND3 antibody at 1/1,000 dilution.
Application
Fig2: Western blot analysis of RND3 on HEK293 (1) and RND3-hIgGFc transfected HEK293 (2) cell lysate using anti-RND3 antibody at 1/1,000 dilution.
Application
Fig3: ICC staining RND3 (green) and Actin filaments (red) in Hela cells. The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.
Application
Fig4:Immunohistochemical analysis of paraffin-embedded human bladder cancer tissue using anti-RND3 antibody. Counter stained with hematoxylin.
Application
Fig5: Flow cytometric analysis of Hela cells with RND3 antibody at 1/100 dilution (green) compared with an unlabelled control (cells without incubation with primary antibody; red).